positive aPL, because risks of emergency contraception are low compared to those of unplanned pregnancy. Levonorgestrel, the over-the-counter option, is widely available and has no medical contraindications to use, including thrombophilia SLE patients. Controlled studies of estrogen-progestin contraceptives in SLE have enrolled only women with stable, low disease activity; they specifically excluded those with high disease activity and history of thrombosis In SLE patients with stable or low